FDA Import Refusal 799-5115689-5/20003/1 — Hetero Labs Limited - Unit III
The FDA refused shipment 799-5115689-5/20003/1 from Hetero Labs Limited - Unit III (India) on January 20, 2026. The refused product falls under Drugs and Biologics — LAMIVUDINE (ANTI-VIRAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- January 20, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62VDA32 LAMIVUDINE (ANTI-VIRAL)
- Charges
- 75